/주식/RPTX
RPTX

RPTX

USD

Repare Therapeutics Inc. Common Shares

$1.780-0.040 (-2.198%)

실시간 가격

Healthcare
생명공학
캐나다

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.820

고가

$1.855

저가

$1.780

거래량

0.15M

기업 기본 정보

시가총액

76.5M

산업

생명공학

국가

Canada

거래 통계

평균 거래량

0.13M

거래소

NMS

통화

USD

52주 범위

저가 $0.89현재가 $1.780고가 $4.069

관련 뉴스

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

더 보기
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

더 보기
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
BusinessWire

Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase

더 보기
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics